Live Breaking News & Updates on Fung Yuen

Stay updated with breaking news from Fung yuen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Arbutus to Present Imdusiran Data at EASL Congress 2024

WARMINSTER, Pa., May 22, 2024 Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with. ....

United States , N Acetylgalactosamine Galnac , Kosh Agarwal , Fung Yuen , Lisam Caperelli , Arbutus Biopharma Corporation Nasdaq , Securities Exchange , World Health Organization , Biopharma Corporation , European Association , Poster Tour , Looking Statements , Securities Act , Securities Exchange Act , Arbutu Annual Report , Arbutu Quarterly Reports ,

Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024

Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , Jordyn Tarazi , Jin Hong , Kosh Agarwal , Fung Yuen , Michael Fitzhugh , Yannick Debing , Kha Le , Lifesci Communications , Division Of Gastroenterology , Aligos Therapeutics Inc , University Of Hong Kong , Exchange Commission , Investor Relations Corporate Communications , Exchange Commission On , King College Hospital , Capsid Assembly Modulator , Therapeutics Announces Six Abstracts Accepted , European Association , Extended Treatment , Viral Markers , Professor Man Fung Yuen , Potent Antiviral Effects Including Suppression , Consultant Hepatologist , Transplant Physician ,

Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update

End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June 2024 Preliminary data from the single-dose portion of the AB-101-001. ....

United States , Katie Anderson , Ram Bhamidimarri , Ronaldg Nahass , Deana Antoniello , Kosh Agarwal , Anita Kohli , Jeong Heo , Gavin Cloherty , Louise Bussey , Naim Alkhouri , Shariec Ganchua , Stuartc Gordon , Christinel Espiritu , Tatiana Burda , Stuart Roberts , Kevin Gray , Tuant Nguyen , Timothy Eley , Michaelj Mcelhaugh , Mark Anderson , Jacinta Holmes , Barinthus Bio , Tiffany Fortney , Karend Sims , Tilly Varughese ,

Aligos Therapeutics Inc. (ALGS) Presents Positive Clinical Data from ALG-055009 and ALG-000184 Phase 1 Studies

Aligos Therapeutics Inc. (ALGS) Presents Positive Clinical Data from ALG-055009 and ALG-000184 Phase 1 Studies
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Lawrence Blatt , Fung Yuen , Jinlin Hou , Megan Fitzgerald , Companyjordyn Tarazivice , Investor Relations Corporate Communications , Southern Medical University , Division Of Gastroenterology , Exchange Commission , Mediamichael Fitzhugh Lifesci Communications , University Of Hong Kong , Exchange Commission On , Department Of Infectious Diseases , Aligos Therapeutics Inc , Aligosaligos Therapeutics Inc , Aligos Therapeutics , Annual Meeting , Asian Pacific Association , Chief Executive Officer , Presentation Title , Multiple Ascending Oral Doses , Entecavir Results , Ag Positive Subjects , Professor Man Fung Yuen , Stronger Antiviral Effects Compared , Professor Jinlin Hou ,

Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies

Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Megan Fitzgerald , Fung Yuen , Lawrence Blatt , Companyjordyn Tarazivice , Jinlin Hou , Department Of Infectious Diseases , Exchange Commission , University Of Hong Kong , Division Of Gastroenterology , Southern Medical University , Mediamichael Fitzhugh Lifesci Communications , Aligos Therapeutics Inc , Exchange Commission On , Investor Relations Corporate Communications , Aligosaligos Therapeutics Inc , Annual Meeting , Asian Pacific Association , Chief Executive Officer , Presentation Title , Multiple Ascending Oral Doses , Entecavir Results , Ag Positive Subjects , Professor Man Fung Yuen , Stronger Antiviral Effects Compared , Professor Jinlin Hou , Hepatology Unit ,